glp 1 agonist gastric emptying GLP-1 receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal. Read Understanding GLP-1 receptor agonists and

10.1007/s12035-015-9156-8 155 MllerM.KuiperijH

Microbiome 7:100

Immunofluorescence staining and western blot results verified that GPX1 expression was absent in the cochlear SGNs of gpx1 / mice (Supplementary Figures 1A,C), and there was no significant difference in SGNs number between the gpx1 / mice and WT mice (Supplementary Figure 1B), which indicated that the absence of GPX1 in normal SGNs would not affect the survival of SGNs

In mice, treated females generated oocytes with improved spindle integrity and reduced DNA fragmentation

When comparing methylcobalamin vs cyanocobalamin, cyanocobalamin is widely used as it is generally considered more cost-effective

Cell 181 , 10041015.e15 (2020)